Evaluation of Risk Factors for Rectus Sheath Hematoma.
Identifieur interne : 000136 ( Main/Exploration ); précédent : 000135; suivant : 000137Evaluation of Risk Factors for Rectus Sheath Hematoma.
Auteurs : Heena S. Sheth [États-Unis] ; Rohit Kumar [États-Unis] ; Jeannine Dinella [États-Unis] ; Cheryl Janov [États-Unis] ; Hoda Kaldas [États-Unis] ; Roy E. Smith [États-Unis]Source :
- Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis [ 1938-2723 ] ; 2016.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Antiagrégants plaquettaires (administration et posologie), Antiagrégants plaquettaires (effets indésirables), Anticoagulants (administration et posologie), Anticoagulants (effets indésirables), Artères épigastriques (imagerie diagnostique), Facteurs de risque, Femelle, Humains, Hématome (imagerie diagnostique), Hématome (mortalité), Hématome (étiologie), Immunosuppresseurs (administration et posologie), Immunosuppresseurs (effets indésirables), Muscle droit de l'abdomen (imagerie diagnostique), Mâle, Plaies et blessures (), Plaies et blessures (imagerie diagnostique), Plaies et blessures (mortalité), Sujet âgé de 80 ans ou plus, Tomodensitométrie, Études rétrospectives.
- MESH :
- administration et posologie : Antiagrégants plaquettaires, Anticoagulants, Immunosuppresseurs.
- effets indésirables : Antiagrégants plaquettaires, Anticoagulants, Immunosuppresseurs.
- imagerie diagnostique : Artères épigastriques, Hématome, Muscle droit de l'abdomen, Plaies et blessures.
- mortalité : Hématome, Plaies et blessures.
- étiologie : Hématome.
- Adulte, Adulte d'âge moyen, Facteurs de risque, Femelle, Humains, Mâle, Plaies et blessures, Sujet âgé de 80 ans ou plus, Tomodensitométrie, Études rétrospectives.
English descriptors
- KwdEn :
- Adult, Aged, 80 and over, Anticoagulants (administration & dosage), Anticoagulants (adverse effects), Epigastric Arteries (diagnostic imaging), Female, Hematoma (diagnostic imaging), Hematoma (etiology), Hematoma (mortality), Humans, Immunosuppressive Agents (administration & dosage), Immunosuppressive Agents (adverse effects), Male, Middle Aged, Platelet Aggregation Inhibitors (administration & dosage), Platelet Aggregation Inhibitors (adverse effects), Rectus Abdominis (diagnostic imaging), Retrospective Studies, Risk Factors, Tomography, X-Ray Computed, Wounds and Injuries (complications), Wounds and Injuries (diagnostic imaging), Wounds and Injuries (mortality).
- MESH :
- chemical , administration & dosage : Anticoagulants, Immunosuppressive Agents, Platelet Aggregation Inhibitors.
- chemical , adverse effects : Anticoagulants, Immunosuppressive Agents, Platelet Aggregation Inhibitors.
- complications : Wounds and Injuries.
- diagnostic imaging : Epigastric Arteries, Hematoma, Rectus Abdominis, Wounds and Injuries.
- etiology : Hematoma.
- mortality : Hematoma, Wounds and Injuries.
- Adult, Aged, 80 and over, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Factors, Tomography, X-Ray Computed.
Abstract
Rectus sheath hematoma (RSH) develops due to rupture of epigastric arteries or the rectus muscle. Although RSH incidence rate is low, it poses a significant diagnostic dilemma. We evaluated the risk factors for RSH, its presentation, management, and outcomes for 115 patients hospitalized with confirmed RSH by computed tomography scan between January 2005 and June 2009. More than three-fourth (77.4%) of the patients were on anticoagulation therapy, 58.3% patients had chronic kidney disease (CKD) stage ≥3, 51.3% had abdominal injections, 41.7% were on steroids/immunosuppressant therapy, 37.4% had abdominal surgery/trauma, 33.9% had cough, femoral puncture was performed in 31.3% of patients, and 29.5% were on antiplatelet therapy. Rectus sheath hematoma was not an attributable cause in any of the 17 deaths. Mortality was significantly higher in patients with CKD stage ≥3 (P = .03) or who required transfusion (P = .007). Better understanding of RSH risk factors will facilitate early diagnoses and improve management.
DOI: 10.1177/1076029614553024
PubMed: 25294636
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000032
- to stream PubMed, to step Curation: 000032
- to stream PubMed, to step Checkpoint: 000032
- to stream Ncbi, to step Merge: 003929
- to stream Ncbi, to step Curation: 003929
- to stream Ncbi, to step Checkpoint: 003929
- to stream Main, to step Merge: 000136
- to stream Main, to step Curation: 000136
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Evaluation of Risk Factors for Rectus Sheath Hematoma.</title><author><name sortKey="Sheth, Heena S" sort="Sheth, Heena S" uniqKey="Sheth H" first="Heena S" last="Sheth">Heena S. Sheth</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA hss2@pitt.edu.</nlm:affiliation><country wicri:rule="url">États-Unis</country><wicri:regionArea>Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Kumar, Rohit" sort="Kumar, Rohit" uniqKey="Kumar R" first="Rohit" last="Kumar">Rohit Kumar</name><affiliation wicri:level="2"><nlm:affiliation>Hematology/Oncology Division, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Hematology/Oncology Division, University of Pittsburgh Medical Center, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Dinella, Jeannine" sort="Dinella, Jeannine" uniqKey="Dinella J" first="Jeannine" last="Dinella">Jeannine Dinella</name><affiliation wicri:level="2"><nlm:affiliation>CV Division, University of Pittsburgh Medical Center Presbyterian, Pittsburgh, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>CV Division, University of Pittsburgh Medical Center Presbyterian, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Janov, Cheryl" sort="Janov, Cheryl" uniqKey="Janov C" first="Cheryl" last="Janov">Cheryl Janov</name><affiliation wicri:level="2"><nlm:affiliation>Risk Management, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Risk Management, University of Pittsburgh Medical Center, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Kaldas, Hoda" sort="Kaldas, Hoda" uniqKey="Kaldas H" first="Hoda" last="Kaldas">Hoda Kaldas</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Smith, Roy E" sort="Smith, Roy E" uniqKey="Smith R" first="Roy E" last="Smith">Roy E. Smith</name><affiliation wicri:level="2"><nlm:affiliation>Hematology/Oncology Division, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Hematology/Oncology Division, University of Pittsburgh Medical Center, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:25294636</idno><idno type="pmid">25294636</idno><idno type="doi">10.1177/1076029614553024</idno><idno type="wicri:Area/PubMed/Corpus">000032</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000032</idno><idno type="wicri:Area/PubMed/Curation">000032</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000032</idno><idno type="wicri:Area/PubMed/Checkpoint">000032</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000032</idno><idno type="wicri:Area/Ncbi/Merge">003929</idno><idno type="wicri:Area/Ncbi/Curation">003929</idno><idno type="wicri:Area/Ncbi/Checkpoint">003929</idno><idno type="wicri:Area/Main/Merge">000136</idno><idno type="wicri:Area/Main/Curation">000136</idno><idno type="wicri:Area/Main/Exploration">000136</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Evaluation of Risk Factors for Rectus Sheath Hematoma.</title><author><name sortKey="Sheth, Heena S" sort="Sheth, Heena S" uniqKey="Sheth H" first="Heena S" last="Sheth">Heena S. Sheth</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA hss2@pitt.edu.</nlm:affiliation><country wicri:rule="url">États-Unis</country><wicri:regionArea>Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Kumar, Rohit" sort="Kumar, Rohit" uniqKey="Kumar R" first="Rohit" last="Kumar">Rohit Kumar</name><affiliation wicri:level="2"><nlm:affiliation>Hematology/Oncology Division, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Hematology/Oncology Division, University of Pittsburgh Medical Center, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Dinella, Jeannine" sort="Dinella, Jeannine" uniqKey="Dinella J" first="Jeannine" last="Dinella">Jeannine Dinella</name><affiliation wicri:level="2"><nlm:affiliation>CV Division, University of Pittsburgh Medical Center Presbyterian, Pittsburgh, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>CV Division, University of Pittsburgh Medical Center Presbyterian, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Janov, Cheryl" sort="Janov, Cheryl" uniqKey="Janov C" first="Cheryl" last="Janov">Cheryl Janov</name><affiliation wicri:level="2"><nlm:affiliation>Risk Management, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Risk Management, University of Pittsburgh Medical Center, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Kaldas, Hoda" sort="Kaldas, Hoda" uniqKey="Kaldas H" first="Hoda" last="Kaldas">Hoda Kaldas</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Smith, Roy E" sort="Smith, Roy E" uniqKey="Smith R" first="Roy E" last="Smith">Roy E. Smith</name><affiliation wicri:level="2"><nlm:affiliation>Hematology/Oncology Division, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Hematology/Oncology Division, University of Pittsburgh Medical Center, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author></analytic><series><title level="j">Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis</title><idno type="eISSN">1938-2723</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged, 80 and over</term><term>Anticoagulants (administration & dosage)</term><term>Anticoagulants (adverse effects)</term><term>Epigastric Arteries (diagnostic imaging)</term><term>Female</term><term>Hematoma (diagnostic imaging)</term><term>Hematoma (etiology)</term><term>Hematoma (mortality)</term><term>Humans</term><term>Immunosuppressive Agents (administration & dosage)</term><term>Immunosuppressive Agents (adverse effects)</term><term>Male</term><term>Middle Aged</term><term>Platelet Aggregation Inhibitors (administration & dosage)</term><term>Platelet Aggregation Inhibitors (adverse effects)</term><term>Rectus Abdominis (diagnostic imaging)</term><term>Retrospective Studies</term><term>Risk Factors</term><term>Tomography, X-Ray Computed</term><term>Wounds and Injuries (complications)</term><term>Wounds and Injuries (diagnostic imaging)</term><term>Wounds and Injuries (mortality)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Antiagrégants plaquettaires (administration et posologie)</term><term>Antiagrégants plaquettaires (effets indésirables)</term><term>Anticoagulants (administration et posologie)</term><term>Anticoagulants (effets indésirables)</term><term>Artères épigastriques (imagerie diagnostique)</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Hématome (imagerie diagnostique)</term><term>Hématome (mortalité)</term><term>Hématome (étiologie)</term><term>Immunosuppresseurs (administration et posologie)</term><term>Immunosuppresseurs (effets indésirables)</term><term>Muscle droit de l'abdomen (imagerie diagnostique)</term><term>Mâle</term><term>Plaies et blessures ()</term><term>Plaies et blessures (imagerie diagnostique)</term><term>Plaies et blessures (mortalité)</term><term>Sujet âgé de 80 ans ou plus</term><term>Tomodensitométrie</term><term>Études rétrospectives</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anticoagulants</term><term>Immunosuppressive Agents</term><term>Platelet Aggregation Inhibitors</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Anticoagulants</term><term>Immunosuppressive Agents</term><term>Platelet Aggregation Inhibitors</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antiagrégants plaquettaires</term><term>Anticoagulants</term><term>Immunosuppresseurs</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Wounds and Injuries</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Epigastric Arteries</term><term>Hematoma</term><term>Rectus Abdominis</term><term>Wounds and Injuries</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antiagrégants plaquettaires</term><term>Anticoagulants</term><term>Immunosuppresseurs</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Hematoma</term></keywords><keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr"><term>Artères épigastriques</term><term>Hématome</term><term>Muscle droit de l'abdomen</term><term>Plaies et blessures</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Hematoma</term><term>Wounds and Injuries</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Hématome</term><term>Plaies et blessures</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Hématome</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged, 80 and over</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Retrospective Studies</term><term>Risk Factors</term><term>Tomography, X-Ray Computed</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Plaies et blessures</term><term>Sujet âgé de 80 ans ou plus</term><term>Tomodensitométrie</term><term>Études rétrospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Rectus sheath hematoma (RSH) develops due to rupture of epigastric arteries or the rectus muscle. Although RSH incidence rate is low, it poses a significant diagnostic dilemma. We evaluated the risk factors for RSH, its presentation, management, and outcomes for 115 patients hospitalized with confirmed RSH by computed tomography scan between January 2005 and June 2009. More than three-fourth (77.4%) of the patients were on anticoagulation therapy, 58.3% patients had chronic kidney disease (CKD) stage ≥3, 51.3% had abdominal injections, 41.7% were on steroids/immunosuppressant therapy, 37.4% had abdominal surgery/trauma, 33.9% had cough, femoral puncture was performed in 31.3% of patients, and 29.5% were on antiplatelet therapy. Rectus sheath hematoma was not an attributable cause in any of the 17 deaths. Mortality was significantly higher in patients with CKD stage ≥3 (P = .03) or who required transfusion (P = .007). Better understanding of RSH risk factors will facilitate early diagnoses and improve management.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Pennsylvanie</li></region></list><tree><country name="États-Unis"><region name="Pennsylvanie"><name sortKey="Sheth, Heena S" sort="Sheth, Heena S" uniqKey="Sheth H" first="Heena S" last="Sheth">Heena S. Sheth</name></region><name sortKey="Dinella, Jeannine" sort="Dinella, Jeannine" uniqKey="Dinella J" first="Jeannine" last="Dinella">Jeannine Dinella</name><name sortKey="Janov, Cheryl" sort="Janov, Cheryl" uniqKey="Janov C" first="Cheryl" last="Janov">Cheryl Janov</name><name sortKey="Kaldas, Hoda" sort="Kaldas, Hoda" uniqKey="Kaldas H" first="Hoda" last="Kaldas">Hoda Kaldas</name><name sortKey="Kumar, Rohit" sort="Kumar, Rohit" uniqKey="Kumar R" first="Rohit" last="Kumar">Rohit Kumar</name><name sortKey="Smith, Roy E" sort="Smith, Roy E" uniqKey="Smith R" first="Roy E" last="Smith">Roy E. Smith</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000136 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000136 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Amérique
|area= PittsburghV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25294636
|texte= Evaluation of Risk Factors for Rectus Sheath Hematoma.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25294636" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a PittsburghV1
| This area was generated with Dilib version V0.6.38. |  |